Technical Analysis for TIL - Instil Bio, Inc.

Grade Last Price % Change Price Change
C 16.42 -9.83% -1.79
TIL closed down 9.83 percent on Tuesday, July 27, 2021, on 56 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical TIL trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -9.83%
Fell Below 50 DMA Bearish -9.83%
Expansion Pivot Sell Setup Bearish Swing Setup -9.83%
Below Lower BB Weakness -9.83%
Older End-of-Day Signals for TIL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 6 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
Down 5% about 7 hours ago
Down 1 ATR about 7 hours ago
Down 3% about 8 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Non Small Cell Lung Cancer Melanoma Cell Therapy Cervical Cancer Lymphocytes Cutaneous Squamous Cell Carcinoma Head And Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer Tumor Infiltrating Lymphocytes

Is TIL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.49
52 Week Low 14.42
Average Volume 387,961
200-Day Moving Average 0.00
50-Day Moving Average 18.22
20-Day Moving Average 19.21
10-Day Moving Average 18.76
Average True Range 1.19
ADX 22.05
+DI 19.10
-DI 27.56
Chandelier Exit (Long, 3 ATRs) 17.29
Chandelier Exit (Short, 3 ATRs) 19.80
Upper Bollinger Bands 20.90
Lower Bollinger Band 17.52
Percent B (%b) -0.33
BandWidth 17.59
MACD Line -0.07
MACD Signal Line 0.22
MACD Histogram -0.2867
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.41
Resistance 3 (R3) 19.67 18.95 18.91
Resistance 2 (R2) 18.95 18.19 18.81 18.74
Resistance 1 (R1) 17.68 17.72 17.32 17.42 18.58
Pivot Point 16.96 16.96 16.78 16.82 16.96
Support 1 (S1) 15.69 16.20 15.33 15.43 14.26
Support 2 (S2) 14.97 15.73 14.83 14.10
Support 3 (S3) 13.70 14.97 13.93
Support 4 (S4) 13.44